Millennium Management »

Monte Rosa Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $380k 67k 5.65
2023-03-31 $912k 117k 7.79
2022-12-31 $3.0M 393k 7.61
2022-06-30 $168k 17k 9.65
2021-09-30 $3.9M 175k 22.28
2021-06-30 $5.3M 235k 22.70

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Amazon Put Option (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
salesforce Put Option (CRM)

View all positions for Millennium Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
Aisling Capital Management
Alphabet
Citadel Advisors
Casdin Capital
Caption Management
Charles Schwab Investment Management
TD Asset Management
Candriam Luxembourg S.C.A.
Bank of New York Mellon
Bank of America Corporation

View all funds holding Monte Rosa Therapeutics